{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:16:27Z","timestamp":1790082987654,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC2703100"],"award-info":[{"award-number":["2022YFC2703100"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences & Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jval.2025.01.006","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:55:57Z","timestamp":1737978957000},"page":"769-780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development and Testing of the Psychometric Properties of 20 Bolt-On Items for the EQ-5D-5L Across 31 Rare Diseases"],"prefix":"10.1016","volume":"28","author":[{"given":"Richard Huan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanni","family":"Rencz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jval.2025.01.006_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol--a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"issue":"3","key":"10.1016\/j.jval.2025.01.006_bib3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11136-020-02688-y","article-title":"Psychometric properties of the EQ-5D-5L: a systematic review of the literature","volume":"30","author":"Feng","year":"2021","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12955-018-0970-3","article-title":"Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective","volume":"16","author":"Whalley","year":"2018","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12955-022-02036-3","article-title":"Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review","volume":"20","author":"Keetharuth","year":"2022","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"10.1016\/j.jval.2025.01.006_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/14737167.2016.1146594","article-title":"Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments","volume":"16","author":"Schwenkglenks","year":"2016","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"10","key":"10.1016\/j.jval.2025.01.006_bib7","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1007\/s11136-022-03138-7","article-title":"Criteria for developing, assessing and selecting candidate EQ-5D bolt-ons","volume":"31","author":"Mulhern","year":"2022","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.jval.2025.01.006_bib8","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ajmg.a.61124","article-title":"The burden of rare diseases","volume":"179","author":"Ferreira","year":"2019","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.jval.2025.01.006_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/d41573-019-00180-y","article-title":"How many rare diseases are there?","volume":"19","author":"Haendel","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13023-022-02343-4","article-title":"Healthcare access, satisfaction, and health-related quality of life among children and adults with rare diseases","volume":"17","author":"Bogart","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"10.1016\/j.jval.2025.01.006_bib11","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/1352458512474860","article-title":"Relating health-related quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D","volume":"19","author":"Fogarty","year":"2013","journal-title":"Mult Scler J"},{"issue":"3","key":"10.1016\/j.jval.2025.01.006_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2014.03.1038","article-title":"Responsiveness of the Eq-5d index and visual analog scale to changes in lung function in patients with cystic fibrosis","volume":"17","author":"Solem","year":"2014","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2025.01.006_bib13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/bjd.16883","article-title":"Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus","volume":"180","author":"Tam\u00e1si","year":"2019","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jval.2025.01.006_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0272989X20978390","article-title":"Assessing the appropriateness of the EQ-5D for Duchenne muscular dystrophy: a patient-centered study","volume":"41","author":"Crossnohere","year":"2021","journal-title":"Med Decis Making"},{"issue":"4","key":"10.1016\/j.jval.2025.01.006_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.21037\/cdt-22-215","article-title":"Quality of life in patients with Fabry\u2019s disease: a cross-sectional study of 86 adults","volume":"12","author":"Andonian","year":"2022","journal-title":"Cardiovasc Diagn Ther"},{"issue":"4","key":"10.1016\/j.jval.2025.01.006_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10198-021-01273-5","article-title":"Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia","volume":"22","author":"Xu","year":"2021","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10198-023-01574-x","article-title":"Assessing validity of the EQ-5D-5L proxy in children and adolescents with Duchenne muscular dystrophy or spinal muscular atrophy","volume":"25","author":"Xu","year":"2024","journal-title":"Eur J Health Econ"},{"issue":"5","key":"10.1016\/j.jval.2025.01.006_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0266462320000665","article-title":"The estimation of health state utility values in rare diseases: overview of existing techniques","volume":"36","author":"Meregaglia","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s41687-021-00336-8","article-title":"Measuring health-related quality of life in patients with rare disease","volume":"5","author":"Lenderking","year":"2021","journal-title":"J\u00a0Patient Rep Outcomes"},{"issue":"4","key":"10.1016\/j.jval.2025.01.006_bib20","first-page":"12","article-title":"Navigating the complexity of rare diseases: challenges, innovations, and future directions","volume":"5","author":"Ibrahim","year":"2023","journal-title":"Glob J Med Ther"},{"issue":"11","key":"10.1016\/j.jval.2025.01.006_bib21","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1007\/s11136-020-02576-5","article-title":"Filling the psycho-social gap in the EQ-5D: the empirical support for four bolt-on dimensions","volume":"29","author":"Chen","year":"2020","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jval.2018.07.001","article-title":"Selecting bolt-on dimensions for the EQ-5D: examining their contribution to health-related quality of life","volume":"22","author":"Finch","year":"2019","journal-title":"Value Health"},{"issue":"10","key":"10.1016\/j.jval.2025.01.006_bib23","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s11136-022-03141-y","article-title":"A\u00a0qualitative investigation of the relevance of skin irritation and self-confidence bolt-ons and their conceptual overlap with the EQ-5D in patients with psoriasis","volume":"31","author":"Rencz","year":"2022","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.jval.2025.01.006_bib24","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s11136-019-02144-6","article-title":"The added value of the EQ-5D with a cognition dimension in injury patients with and without traumatic brain injury","volume":"28","author":"Geraerds","year":"2019","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1016\/j.jval.2025.01.006_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11136-022-03214-y","article-title":"Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia","volume":"32","author":"Campbell","year":"2023","journal-title":"Qual Life Res"},{"issue":"8","key":"10.1016\/j.jval.2025.01.006_bib26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jval.2015.08.002","article-title":"A\u00a0vision \u201cbolt-on\u201d item could increase the discriminatory power of the EQ-5D index score","volume":"18","author":"Luo","year":"2015","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jval.2025.01.006_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2015.09.2695","article-title":"Development of an Eq-5d respiratory bolt-on","volume":"18","author":"Hoogendoorn","year":"2015","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.jval.2025.01.006_bib28","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1038\/s41433-021-01414-3","article-title":"Predicting quality of life in AMD patients\u2014insights on the new NICE classification and on a bolt-on vision dimension for the EQ-5D","volume":"35","author":"De Sousa Peixoto","year":"2021","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.jval.2025.01.006_bib29","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s11136-018-2072-4","article-title":"Exploration of a cultural-adaptation of the EQ-5D for Thai population: a \u201cbolt-on\u201d experiment","volume":"28","author":"Kangwanrattanakul","year":"2019","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2025.01.006_bib30","article-title":"Investigating the added value of the EQ-5D-5L with two bolt-on items in patients with hemophilia","volume":"8","author":"Xu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jval.2025.01.006_bib31","doi-asserted-by":"crossref","DOI":"10.2196\/50147","article-title":"Measurement of health-related quality of life in individuals with rare diseases in China: nation-wide online survey","volume":"9","author":"Xu","year":"2023","journal-title":"JMIR Public Health Surveill"},{"issue":"10","key":"10.1016\/j.jval.2025.01.006_bib32","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.jval.2025.01.006_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A\u00a012-item short-form health survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.jval.2025.01.006_bib34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-B","article-title":"The MOS social support survey","volume":"32","author":"Sherbourne","year":"1991","journal-title":"Soc Sci Med"},{"issue":"7","key":"10.1016\/j.jval.2025.01.006_bib35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jval.2024.03.2195","article-title":"Patient-reported outcomes testing the psychometric properties of 9 bolt-ons for the EQ-5D-5L in a general population sample","volume":"27","author":"Rencz","year":"2024","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A\u00a0power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"issue":"6","key":"10.1016\/j.jval.2025.01.006_bib37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40273-018-0623-8","article-title":"Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries","volume":"36","author":"Janssen","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11136-021-02922-1","article-title":"Combining EQ-5D-5L items into a level summary score: demonstrating feasibility using non-parametric item response theory using an international dataset","volume":"31","author":"Feng","year":"2022","journal-title":"Qual Life Res"},{"issue":"11","key":"10.1016\/j.jval.2025.01.006_bib39","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/bph.16337","article-title":"Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: a year in review","volume":"181","author":"Papapetropoulos","year":"2024","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12955-015-0307-4","article-title":"The psychometric performance of generic preference-based measures for patients with pressure ulcers","volume":"13","author":"Palfreyman","year":"2015","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"10.1016\/j.jval.2025.01.006_bib41","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/07853890109002086","article-title":"The 15D instrument of health-related quality of life: properties and applications","volume":"33","author":"Sintonen","year":"2001","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.jval.2025.01.006_bib42","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1524-4733.2009.00526.x","article-title":"Assessing utility where short measures are required: development of the short assessment of quality of life-8 (AQoL-8) Instrument","volume":"12","author":"Hawthorne","year":"2009","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2025.01.006_bib43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jval.2022.01.009","article-title":"The EQ-HWB: overview of the development of a measure of health and wellbeing and key results","volume":"25","author":"Brazier","year":"2022","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.jval.2025.01.006_bib44","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.jval.2021.05.006","article-title":"Performance of the EQ-5D-5L plus respiratory Bolt-On in the Birmingham chronic obstructive pulmonary disease cohort study","volume":"24","author":"Hoogendoorn","year":"2021","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066445","article-title":"Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG","volume":"13","author":"Dewilde","year":"2023","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.jval.2025.01.006_bib46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10198-019-01156-w","article-title":"A\u00a0vision \u2018bolt-on\u2019 increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery","volume":"21","author":"Gandhi","year":"2020","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2025.01.006_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081140","article-title":"Developing and testing culturally relevant bolt-on items for EQ-5D-5L in Chinese populations: a mixed-methods study protocol","volume":"14","author":"Mao","year":"2024","journal-title":"BMJ Open"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:00:17Z","timestamp":1778590817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1098301525000245"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.01.006","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Testing of the Psychometric Properties of 20 Bolt-On Items for the EQ-5D-5L Across 31 Rare Diseases","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}